| Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients N Kamar, F Abravanel, O Marion, C Couat, J Izopet, A Del Bello New England Journal of Medicine 385 (7), 661-662, 2021 | 855 | 2021 |
| 2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection AJ Demetris, C Bellamy, SG Hübscher, J O’leary, PS Randhawa, S Feng, ... American Journal of Transplantation 16 (10), 2816-2835, 2016 | 515 | 2016 |
| Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation N Kamar, O Marion, L Rostaing, O Cointault, D Ribes, L Lavayssière, ... American Journal of Transplantation 16 (5), 1474-1479, 2016 | 243 | 2016 |
| Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study J Coussement, ... Reviews of Infectious Diseases 63 (3), 338-345, 2016 | 198 | 2016 |
| Drug-resistant cytomegalovirus in transplant recipients: a French cohort study S Hantz, F Garnier-Geoffroy, MC Mazeron, I Garrigue, P Merville, ... Journal of antimicrobial chemotherapy 65 (12), 2628-2640, 2010 | 171 | 2010 |
| Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial RK Avery, S Alain, BD Alexander, EA Blumberg, RF Chemaly, ... Clinical Infectious Diseases 75 (4), 690-701, 2022 | 158 | 2022 |
| Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study H Holdaas, L Rostaing, D Serón, E Cole, J Chapman, B Fellstrøm, ... Transplantation 92 (4), 410-418, 2011 | 156 | 2011 |
| Correction of postkidney transplant anemia reduces progression of allograft nephropathy G Choukroun, N Kamar, B Dussol, I Etienne, E Cassuto-Viguier, ... Journal of the American Society of Nephrology 23 (2), 360-368, 2012 | 154 | 2012 |
| Safety and immunogenicity of anti–SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants O Marion, A Del Bello, F Abravanel, C Couat, S Faguer, L Esposito, ... Annals of internal medicine 174 (9), 1336-1338, 2021 | 146 | 2021 |
| Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients C Couchoud, F Bayer, C Ayav, C Béchade, P Brunet, F Chantrel, L Frimat, ... Kidney international 98 (6), 1519-1529, 2020 | 146 | 2020 |
| Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients A Del Bello, F Abravanel, O Marion, C Couat, L Esposito, L Lavayssière, ... American Journal of Transplantation 22 (1), 322, 2022 | 144 | 2022 |
| Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis X Iriart, TC Belval, J Fillaux, L Esposito, RA Lavergne, ... American journal of transplantation 15 (1), 190-199, 2015 | 141 | 2015 |
| Diabetes mellitus after kidney transplantation: a French multicentre observational study N Kamar, C Mariat, M Delahousse, J Dantal, A Al Najjar, E Cassuto, ... Nephrology Dialysis Transplantation 22 (7), 1986-1993, 2007 | 139 | 2007 |
| Efficacy of sofosbuvir and daclatasvir in patients with fibrosing cholestatic hepatitis C after liver transplantation V Leroy, J Dumortier, A Coilly, M Sebagh, C Fougerou-Leurent, ... Clinical Gastroenterology and Hepatology 13 (11), 1993-2001. e2, 2015 | 132 | 2015 |
| Poor anti-SARS-CoV-2 humoral and T-cell responses after 2 injections of mRNA vaccine in kidney transplant recipients treated with belatacept N Chavarot, A Ouedrani, O Marion, M Leruez-Ville, E Vilain, M Baaziz, ... Transplantation 105 (9), e94-e95, 2021 | 131 | 2021 |
| Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop A Tong, B Manns, AYM Wang, B Hemmelgarn, DC Wheeler, J Gill, ... Kidney international 94 (6), 1053-1068, 2018 | 122 | 2018 |
| Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial K Budde, S Bunnapradist, JM Grinyo, K Ciechanowski, JE Denny, ... American journal of transplantation 14 (12), 2796-2806, 2014 | 118 | 2014 |
| Assessment of 4 doses of SARS-CoV-2 messenger RNA–based vaccine in recipients of a solid organ transplant N Kamar, F Abravanel, O Marion, R Romieu-Mourez, C Couat, A Del Bello, ... JAMA network open 4 (11), e2136030-e2136030, 2021 | 116 | 2021 |
| Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized … WH Marks, N Mamode, RA Montgomery, MD Stegall, LE Ratner, ... American Journal of Transplantation 19 (10), 2876-2888, 2019 | 112 | 2019 |
| Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes G Canaud, N Kamar, D Anglicheau, L Esposito, M Rabant, LH Noël, ... American journal of transplantation 13 (8), 2179-2185, 2013 | 111 | 2013 |
